L-Cin Syrup contains Levofloxacin 125 mg, a broad-spectrum fluoroquinolone antibiotic effective against a variety of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain gastrointestinal infections caused by susceptible strains of bacteria. Levofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, thereby preventing bacterial cell division and leading to cell death. L-Cin Syrup is formulated for pediatric and adult patients who require an oral suspension form for ease of administration. The dosage and duration of therapy should be determined based on the severity of infection, patient age, weight, and renal function. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as potential central nervous system effects like headache and dizziness. It is contraindicated in patients with known hypersensitivity to fluoroquinolones and should be used with caution in individuals with a history of tendon disorders or QT prolongation. Adequate hydration is recommended during therapy to prevent crystalluria. L-Cin Syrup should be used strictly under medical supervision to ensure appropriate use and to minimize the risk of antibiotic resistance.